President Trump recently signed an executive order to increase production of essential medical supplies in the US and cut down reliance on foreign producers.
The executive order signed Thursday...
Knowledge Ecology International (KEI) recently filed a petition calling on the FDA to ban music in the sections of direct-to-consumer advertisements for pharmaceuticals that address side effects and...
Thermo Fisher Scientific and Lyell Immunopharma recently partnered to develop manufacturing processes create more effective cell therapies to benefit cancer patients.
The companies main goal is to...
Despite investing a much larger share of its revenue in research and development (R&D), the pharmaceutical industry retains a smaller share of total spending on its products than other...
HHS and the Department of Defense (DoD) recently announced a $1.6 billion agreement with Novavax Inc. to demonstrate commercial-sale manufacturing of the company’s COVID-19 investigational...
After an ongoing battle, the United States Court of Appeals for the Federal Circuit recently held in Amgen's favor on the validity of two patents that describe and claim Enbrel (etanercept)...
Pharmaceutical companies significantly increased drug costs for 245 drugs between January 20 and June 20, with more than 75 percent of the drugs impacted directly pertaining to COVID-19, according to a...
Allergan, an AbbVie company, recently announced that the FDA accepted its supplemental biologics license application (sBLA) to expand BOTOX prescribing information for bladder (detrusor) overactivity...
Roche recently announced positive phase 3 results from a study evaluating Venclexta (venetoclax) in individuals with untreated acute myeloid leukemia (AML) who were ineligible for intensive induction...
New real-world data recently showed that Trulicity had significantly higher patient adherence and longer persistence compared to weekly injections of semaglutide or exenatide in individuals with type 2...
A coalition of 51 attorney generals from around the US recently filed an antitrust complaint alleging that over two dozen drug manufacturers inflated the price of generic drugs illegally.
The...
Gilead Sciences recently announced positive results from its Phase 3 SIMPLE clinical trial evaluating remdesivir as a COVID-19 drug for moderately ill COVID-19 patients.
For more coronavirus updates,...
Bristol Myers Squibb recently announced that Zeposia (ozanimod) 0.92 mg for the treatment of relapsing multiple sclerosis (MS) is now commercially available in the US.
Ozanimod, developed by...
Bristol Myer’s Squibb drug, nivolumab, did not improve overall survival compared with the drug bevacizumab in the treatment of recurrent glioblastoma in a phase 3 clinical trial, according to a...
Women who obtained direct contraceptive prescriptions from their pharmacist were able to minimize breaks in contraceptive coverage, while increasing their continuous adherence, according to researchers...
A recent study found that the biopharmaceutical industry will be negatively effected by the COVID-19 pandemic and policymakers should make changes to avoid the impact.
For more coronavirus...
The Department of Justice will soon decide whether to charge Teva Pharmaceuticals for an alleged healthcare fraud scheme to fix prices of certain generic medicines. But the company isn’t...
HHS recently announced that it will expand pharmaceutical manufacturing in the US to produce medicines needed during the COVID-19 pandemic and boost capacity for producing finished generic drugs.
For...
FDA recently approved Roche’s first-line treatment, Tecentriq (atezolizumab), for adult patients with metastatic non-small cell lung cancer.
Atezolizumab is the fourth indication in metastatic...
The Trump Administration recently released framework and leadership for Operation Warp Speed (OWS), a new program designed to accelerate the development, manufacturing, and distribution of COVID-19...
